Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 4.75T | 4.40T | 3.98T | 3.11T | 2.49T |
Gross Profit | 1.63T | 1.51T | 1.33T | 1.06T | 864.14B |
EBITDA | 665.14B | 645.76B | 559.26B | 464.41B | 372.22B |
Net Income | 264.76B | 260.31B | 257.75B | 217.71B | 156.25B |
Balance Sheet | |||||
Total Assets | 5.13T | 4.88T | 4.30T | 3.82T | 3.24T |
Cash, Cash Equivalents and Short-Term Investments | 802.66B | 737.96B | 617.66B | 817.62B | 736.10B |
Total Debt | 986.85B | 968.18B | 887.63B | 824.81B | 751.21B |
Total Liabilities | 2.27T | 2.19T | 2.02T | 1.82T | 1.54T |
Stockholders Equity | 2.81T | 2.64T | 2.24T | 1.97T | 1.67T |
Cash Flow | |||||
Free Cash Flow | 268.46B | 156.93B | -16.18B | 130.97B | 269.72B |
Operating Cash Flow | 514.45B | 399.57B | 158.90B | 245.07B | 374.69B |
Investing Cash Flow | -337.41B | -227.19B | -229.79B | -180.79B | -159.67B |
Financing Cash Flow | -153.47B | -129.62B | -113.09B | -48.70B | 98.94B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $39.76B | 20.90 | 10.29% | 1.21% | 3.47% | 16.40% | |
76 Outperform | $15.67B | 20.37 | 31.34% | 1.09% | 1.37% | 5.96% | |
75 Outperform | $95.70B | 34.13 | 38.89% | 0.83% | 10.20% | 24.57% | |
73 Outperform | $20.45B | 24.89 | 112.94% | 0.82% | 7.92% | 29.72% | |
72 Outperform | $69.07B | 31.35 | 12.52% | 1.40% | -13.10% | 40.62% | |
68 Neutral | $56.19B | 26.35 | 10.79% | 1.31% | -5.24% | -33.37% | |
66 Neutral | £2.68B | 12.78 | 3.50% | 3.22% | 2.47% | -24.22% |